Shandong Sinobioway Biomedicine Co., Ltd.
Shandong Sinobioway Biomedicine Co., Ltd. manufactures and supplies trimethyl orthoformate, triethyl orthoformate, trimethyl orthoacetate, phosphorous acid, ethyl formate, nerve growth factor, and alfaron in China. The company also provides NOBEX, a muri…
Chemicals - Specialty
CN, Zibo [HQ]
Ratios
15 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 48.47 | 47.87 | 47.78 | 44.65 | 43.86 | 39.96 | 83.41 | 76.33 | 78.01 | 85.17 | 86.94 | 80.38 | 78.69 | 78.66 | 80.60 | |
| Profit Margin | 27.51 | 28.42 | 27.19 | 30.23 | 27.75 | 25.53 | 29.16 | 33.02 | 33.41 | -14.41 | 11.17 | -71.59 | 67.29 | -0.24 | -77.35 | |
| Operating Margin | 33.39 | 33.94 | 31.76 | 35.43 | 32.26 | 29.54 | 32.17 | 35.51 | 40.02 | -13.13 | 18.65 | -85.92 | 67.81 | 9.43 | -68.25 | |
|
EPS Growth
|
55.56 | 17.86 | -18.18 | 14.82 | 3.23 | 84.38 | -5.09 | 12.50 | -6.35 | -125.42 | 164.07 | -412.18 | 236.67 | -100.32 | -38,361.54 | |
| EPS CNY | 28.00 | 33.00 | 27.00 | 31.00 | 32.00 | 59.00 | 56.00 | 63.00 | 59.00 | -15.00 | 9.61 | -30.00 | 41.00 | -0.13 | -50.00 | |
| Return on Assets (ROA) | 35.66 | 33.51 | 9.70 | 11.83 | 11.38 | 10.59 | 10.36 | 15.54 | 9.72 | -2.23 | 1.86 | -8.11 | 9.83 | -0.03 | -14.23 | |
| Return on Equity (ROE) | 45.35 | 39.62 | 9.96 | 12.25 | 11.92 | 10.87 | 12.00 | 16.91 | 13.60 | -3.48 | 2.74 | -9.36 | 11.35 | -0.04 | -16.07 | |
| Return on Invested Capital (ROIC) | 40.35 | 35.47 | 9.85 | 12.05 | 10.21 | 8.22 | 10.70 | 16.59 | 10.45 | -2.41 | 3.19 | -10.23 | 10.65 | -0.09 | -14.48 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | 100 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 12.13 | 9.54 | - - | 1.28 | 15.06 | 29.51 | 4.70 | 0.04 | 22.31 | 28.95 | 24.76 | 6.83 | 6.43 | 5.79 | 0.62 | |
| Debt/Equity | 15.42 | 11.28 | - - | 1.32 | 15.79 | 30.30 | 5.45 | 0.04 | 31.22 | 45.15 | 36.57 | 7.89 | 7.42 | 6.97 | 0.70 | |
| Debt/EBITDA | -26.40 | -63.03 | -604.32 | -441.50 | -336.89 | -235.93 | -217.83 | -146.10 | -168.83 | -127.58 | -168.21 | 237.12 | -3.01 | -17.40 | -236.63 | |
|
Debt/Capitalization
|
13.36 | 10.13 | - - | 1.30 | 13.64 | 23.25 | 5.17 | 0.04 | 23.79 | 31.11 | 26.77 | 7.31 | 6.91 | 6.51 | 0.70 | |
| Long-Term Debt/Capitalization | - - | - - | - - | 1.30 | 3.69 | 0.61 | 0.05 | 0.02 | 21.69 | 22.36 | 23.12 | 1.29 | 0.41 | 0.06 | 0.03 | |
| Interest Debt per Share CNY | 0.10 | 0.10 | - - | 0.03 | 0.45 | 0.63 | 0.29 | 0.01 | 1.37 | 2.00 | 1.34 | 0.29 | 0.28 | 0.26 | 0.04 | |
| Debt Growth | - - | - - | -100.00 | - - | - - | 94.81 | -49.97 | -99.16 | 93,780.44 | 39.37 | -31.99 | -83.52 | 27.16 | -6.67 | -91.20 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 286.51 | 385.74 | 3,259.11 | 2,508.03 | 1,731.74 | 3,202.26 | 603.71 | 1,179.95 | 1,063.33 | 502.44 | 751.99 | 370.37 | 219.87 | 142.30 | 371.77 | |
| Quick Ratio | 263.40 | 351.68 | 3,210.62 | 2,406.29 | 1,653.56 | 3,020.50 | 577.28 | 1,130.19 | 1,039.93 | 494.99 | 724.23 | 336.11 | 194.99 | 120.32 | 307.91 | |
| Cash Ratio | 118.09 | 242.09 | 2,966.98 | 2,143.88 | 1,404.83 | 2,537.98 | 371.44 | 599.05 | 707.18 | 273.31 | 468.02 | 137.36 | 72.64 | 50.46 | 113.70 | |
| Operating Cash Flow Ratio | 100 | 200 | 400 | 200 | 200 | 400 | - - | 100 | 100 | - - | - - | - - | - - | - - | - - | |
| Turnover | ||||||||||||||||
| Inventory Turnover | 1,352.85 | 1,169.86 | 1,480.94 | 692.61 | 684.26 | 589.55 | 229.08 | 468.54 | 425.43 | 233.93 | 111.51 | 76.66 | 133.42 | 95.21 | 97.75 | |
| Receivables Turnover | 416.65 | 669.96 | 563.65 | 484.20 | 382.75 | 369.58 | 177.04 | 185.40 | 136.16 | 60.88 | 96.58 | 71.84 | 130.73 | 147.22 | 168.55 | |
| Payables Turnover | 2,150.14 | 3,470.87 | 1,747.95 | 1,065.81 | 880.30 | 2,014.03 | 510.00 | 868.47 | 973.27 | 301.40 | 245.69 | 375.81 | 203.73 | 174.65 | 113.17 | |
|
Asset Turnover
|
129.62 | 117.88 | 35.70 | 39.14 | 41.00 | 41.47 | 35.53 | 47.06 | 29.08 | 15.48 | 16.63 | 11.32 | 14.61 | 12.49 | 18.39 | |
| Fixed Turnover | 475.83 | 517.83 | 352.74 | 232.87 | 197.13 | 196.83 | 180.33 | 262.32 | 244.35 | 85.73 | 72.69 | 40.43 | 56.42 | 50.62 | 120.02 | |
| Coverage | ||||||||||||||||
| Interest Coverage | 7,626.90 | 8,833.81 | 19,281.55 | - - | 1,185.47 | 703.60 | 1,663.49 | 8,988.32 | 3,099.54 | -111.62 | 259.10 | -935.53 | 3,969.72 | 357.81 | -3,397.04 | |
| Asset Coverage | 600 | 800 | - - | - - | 600 | 400 | 1,900 | 259,400 | 400 | 300 | 300 | 1,600 | 1,400 | 1,500 | 14,400 | |
| Cash Flow Coverage (CFGR) | 270.28 | 428.56 | - - | 677.80 | 71.32 | 35.28 | 121.24 | 17,822.64 | 30.40 | 5.99 | 5.73 | 11.08 | -25.97 | -32.95 | -250.95 | |
| EBITDA Coverage | 8,700 | 9,700 | 21,600 | - - | 1,200 | 700 | 2,100 | 10,500 | 3,600 | 300 | 400 | -200 | 5,100 | 1,100 | 600 | |
| Dividend Coverage | -100 | -200 | -100 | -100 | -100 | -100 | -1,400 | -1,100 | -763,500 | 100 | -100 | 300 | -4,000 | - - | 3,200 | |
| Time Interest Earned (TIE) | 300 | 300 | 200 | 300 | 300 | 200 | 100 | 100 | 100 | 100 | - - | - - | - - | - - | - - | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | 2.94 | 1.51 | 3.05 | 3.17 | 2.74 | 1.08 | 0.11 | 0.23 | - - | 1.77 | 1.26 | 0.46 | 0.05 | 0.08 | 0.11 | |
| Earnings Yield | 3.74 | 4.51 | 4.68 | 5.06 | 4.46 | 1.25 | 1.61 | 2.61 | 3.07 | -2.25 | 1.33 | -1.64 | 1.92 | -0.01 | -3.45 | |
|
Price/Earnings (P/E)
|
2,676.71 | 2,215.21 | 2,138.29 | 1,976.69 | 2,243.58 | 7,989.14 | 6,197.49 | 3,833.37 | 3,256.12 | -4,448.22 | 7,535.85 | -6,102.09 | 5,197.52 | -1,196,837.79 | -2,897.40 | |
| Price/Earnings Growth (PEG) | 48.18 | 124.05 | -117.61 | 133.43 | 695.51 | 94.69 | -1,218.84 | 306.67 | -512.84 | 35.47 | -45.93 | 14.80 | -21.96 | 11,930.55 | -0.08 | |
|
Price/Book (P/B)
|
1,213.93 | 877.58 | 213.03 | 242.09 | 267.53 | 868.62 | 743.94 | 648.39 | 442.73 | 154.77 | 206.60 | 571.17 | 589.79 | 437.78 | 465.69 | |
| Price/Tangible Book (P/TB) | 1,213.93 | 877.58 | 213.03 | 242.09 | 267.53 | 868.62 | 743.94 | 648.39 | 442.73 | 154.77 | 206.60 | 571.17 | 589.79 | 437.78 | 465.69 | |
| Price/Sales (P/S) | 736.46 | 629.64 | 581.30 | 597.63 | 622.59 | 2,039.68 | 1,807.03 | 1,265.87 | 1,088.00 | 641.13 | 841.47 | 4,368.36 | 3,497.62 | 2,909.94 | 2,241.24 | |
|
Price/Cash Flow (P/CF)
|
2,912.75 | 1,815.74 | 1,924.24 | 2,705.32 | 2,375.94 | 8,125.82 | 11,260.88 | 9,456.80 | 4,665.00 | 5,722.72 | 9,865.80 | 65,331.30 | -30,610.16 | -19,070.97 | -26,386.33 | |
| Price/Free CF (P/FCF) | 4,097.33 | 2,777.25 | 3,029.21 | 184,888.26 | 4,849.65 | 10,937.71 | 16,837.38 | 12,847.61 | 6,911.97 | -798.21 | 39,344.07 | -24,585.81 | -13,181.00 | -12,089.56 | -23,594.98 | |
| Price/Operating CF (P/OCF) | 2,912.75 | 1,815.74 | 1,924.24 | 2,705.32 | 2,375.94 | 8,125.82 | 11,260.88 | 9,456.80 | 4,665.00 | 5,722.72 | 9,865.80 | 65,331.30 | -30,610.16 | -19,070.97 | -26,386.33 |